NAVIFY® Tumor Board solution

What if connecting data influenced patient outcomes?

Oncology care teams currently use antiquated review processes to determine action plans for patients. With mass quantities of data hosted in various locations and formats, there is little continuity in the tumor board workflow.

The NAVIFY® Tumor Board solution is a comprehensive cancer care dashboard that fundamentally changes the way oncology care teams prepare for, conduct, and document clinical treatment decisions.

Minimizing upfront work lets teams focus on individualized treatment decisions—reviewing, determining, and better managing care, start to finish. 

“Improved workflow efficiency with shorter tumor board preparation time for oncologists (-53%), radiologists (-12%) and surgeons (-8%).1

Sign up for a 90-day free trial of NAVIFY Tumor Board!
Sign up
Built to keep healthcare data safe

Data privacy and security is a core focus of this purpose-built cloud-based solution and Roche partners with ClearDATA and Amazon Web Services for built-in data security services across the NAVIFY platform.

The NAVIFY Tumor Board solution is hosted on a secure, compliant cloud infrastructure and operates in alignment with privacy laws in the US and EU, meeting local, regional and country-specific privacy and security regulations.

  • Aligns with HIPAA principles
  • ISO 27001 and HITRUST certified infrastructure
  • Extensive penetration testing throughout development

NAVIFY aggregates information from external sources and does not own or house personally identifiable data (PID) to ensure proper handling of sensitive information    

Reference:

1. Journal of Pathology Informatics, “A new software platform to improve multi-disciplinary tumor board workflows and user satisfaction: A pilot study,” July 2018.

NAVIFY® Tumor Board solution’s EMR-agnostic integration strategy is designed to reduce the interface development burden for by employing commonly used integration standards and patterns.

NAVIFY is a registered trademark of Roche.